IMPACT: Illness Management and Parental Adjustment to Cancer Treatment

Sponsor
Children's Hospital Medical Center, Cincinnati (Other)
Overall Status
Completed
CT.gov ID
NCT02505165
Collaborator
University of Oklahoma (Other), Oklahoma State University (Other), Dayton Children's Hospital (Other)
279
3
2
74.4
93
1.2

Study Details

Study Description

Brief Summary

The purpose of this study is to test the efficacy of a clinic-based intervention designed to reduce illness uncertainty for parents of children who have been recently diagnosed with cancer.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: IMPACT
  • Other: ESO
N/A

Detailed Description

The proposed trial will test the efficacy of the parent-focused clinic-based Parent Uncertainty Management Intervention (PUMI) to improve the outcomes of children newly diagnosed with cancer and their parents. Participants will be randomly assigned to receive equivalent doses of either the PUMI or an Education/Support (ESO) group. Theoretically driven by Mishel's model of illness uncertainty, the PUMI will teach parents about uncertainty prevention and management through the use of medically-specific communication, information management, and problem-solving skills via in-clinic sessions and an online portal. Parents and children will complete measures online at baseline, 1-week, and 3-, 6-, and 12-month follow-ups.

Study Design

Study Type:
Interventional
Actual Enrollment :
279 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Clinic-Based Interdisciplinary Intervention for Parents of Children With Cancer
Actual Study Start Date :
Nov 19, 2015
Actual Primary Completion Date :
Apr 22, 2021
Actual Study Completion Date :
Feb 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Parent Uncertainty Intervention

A pediatric cancer-specific, clinic based, six-module interdisciplinary uncertainty intervention. Modules one through three target uncertainty prevention. Modules four through six target uncertainty responses for situations in which uncertainty cannot be prevented or avoided.

Behavioral: IMPACT
• The intervention is 6 sessions lasting approximately 45 minutes reviewing ways to help prevent and respond to illness uncertainty. Sessions occur weekly at already scheduled clinic appointments. Interventions will be delivered by a trained interventionist.
Other Names:
  • Parent Uncertainty Management Intervention
  • Other: Education/Support Only

    Sessions in this condition aim to provide education on cancer etiology, medical treatments, side effects, potential short- and long-term effects of treatment and resources that are often helpful to parents of children with cancer. Information presented will be based upon, "Young People with Cancer: A Handbook for Parents", a parent resource developed by the National Cancer Institute. Parents will also be provided with relevant educational brochures from COG. Each session will also include a structured set of questions that will facilitate discussion. All ESO interventionists will be trained in non-directive approaches including reflective listening. Content provided in the ESO sessions will offer valuable information to parents without providing the specific skills of the IMPACT.

    Other: ESO
    This control is 6 sessions lasting approximately 45 minutes providing education on cancer etiology, medical treatments, side effects, potential short- and long-term effects of treatment and resources that are often helpful to parents of children with cancer. Sessions occur weekly at already scheduled clinic appointments. Interventions will be delivered by a trained interventionist.
    Other Names:
  • Education/Support Only
  • Outcome Measures

    Primary Outcome Measures

    1. Psychosocial Functioning as assessed by the global severity index (GSI) of the symptom checklist 90. [Change in (global severity index) GSI score from baseline to 1-week post-intervention]

      indicator of global psychological symptoms

    2. Psychosocial Functioning as assessed by the global severity index of the symptom checklist 90. [Change in GSI score from baseline to 3-month post-intervention]

      indicator of global psychological symptoms

    3. Psychosocial Functioning as assessed by the global severity index of the symptom checklist 90. [Change in GSI score from baseline to 6-month post-intervention]

      indicator of global psychological symptoms

    4. Psychosocial Functioning as assessed by the global severity index of the symptom checklist 90. [Change in GSI score from baseline to 12-month post-intervention]

      indicator of global psychological symptoms

    Secondary Outcome Measures

    1. Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R) [Change in IES-R total score score from baseline to 1-week post-intervention]

      Measure of caregiver post-traumatic stress symptoms

    2. Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R) [Change in IES-R total score score from baseline to 3-month post-intervention]

      Measure of caregiver post-traumatic stress symptoms

    3. Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R) [Change in IES-R total score score from baseline to 6-month post-intervention]

      Measure of caregiver post-traumatic stress symptoms

    4. Post-Traumatic Stress Symptoms as assessed by the Impact of Events Scale-Revised (IES-R) [Change in IES-R total score score from baseline to 12-month post-intervention]

      Measure of caregiver post-traumatic stress symptoms

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    0 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • The child has been diagnosed with leukemia or lymphoma, malignant solid tumor, or malignant brain tumor

    • The child is being treated for cancer and returning to the medical center (CCHMC or OUHSC).

    • The child is 18 years of age or younger

    • Recruitment occurs within 2-12 weeks post diagnosis

    • The parent is responsible for care and is willing to give consent and participate

    • The child is willing to give assent or consent and participate (only for children 8 years old and older)

    • The parent gives patient permission to participate.

    • Parent is fluent in English

    Exclusion Criteria:
    • The child is experiencing an imminent medical crisis necessitating significant medical intervention

    • The child with cancer is determined to be in the terminal phase of illness and/or is receiving end of life care

    • The diagnosis is determined to be a relapse or a second malignancy

    • The parent is currently being treated for a serious psychiatric disorder, or, evidences mental retardation

    • The parent is younger than 18 years of age

    • The parent is not English speaking

    • The parent is unwilling to give written permission for child participation

    • If the patient's treatment visit schedule is too infrequent to meet the study visit timeline requirements

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cincinnati Children's Hospital Medical Center Cincinnati Ohio United States 45229
    2 Dayton Children's Hospital Dayton Ohio United States 45404
    3 University of Oklahoma Health Sciences Center Oklahoma City Oklahoma United States 73104

    Sponsors and Collaborators

    • Children's Hospital Medical Center, Cincinnati
    • University of Oklahoma
    • Oklahoma State University
    • Dayton Children's Hospital

    Investigators

    • Principal Investigator: Ahna LH Pai, PhD, Children's Hospital Medical Center, Cincinnati

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Children's Hospital Medical Center, Cincinnati
    ClinicalTrials.gov Identifier:
    NCT02505165
    Other Study ID Numbers:
    • NR014248
    First Posted:
    Jul 22, 2015
    Last Update Posted:
    Apr 13, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Children's Hospital Medical Center, Cincinnati
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 13, 2022